Risk Factors of Emergency Room Visits for Bleeding Complications Following Transurethral Procedures in the Treatment of Benign Prostatic Hyperplasia: A Retrospective Cohort Study

References

• EganKB. The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin North Am. 2016;43(3):289–297.27476122
   PubMed Web of Science ®Google Scholar
• TeoJS, LeeYM, HoHSS. An update on transurethral surgery for benign prostatic obstruction. Asian J Urol. 2017;4(3):195–198.29264231
   PubMed Web of Science ®Google Scholar
• CornuJN, AhyaiS, BachmannA, et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol. 2015;67(6):1066–1096.24972732
   PubMed Web of Science ®Google Scholar
• MayerEK, KroezeSG, ChopraS, BottleA, PatelA. Examining the ‘gold standard’: a comparative critical analysis of three consecutive decades of monopolar transurethral resection of the prostate (TURP) outcomes. BJU Int. 2012;110(11):1595–1601.22540956
   PubMed Web of Science ®Google Scholar
• AhyaiSA, GillingP, KaplanSA, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58(3):384–397.20825758
   PubMed Web of Science ®Google Scholar
• IssaMM. Technological advances in transurethral resection of the prostate: bipolar versus monopolar TURP. J Endourol. 2008;22(8):1587–1595.18721041
   PubMed Web of Science ®Google Scholar
• NairSM, PimentelMA, GillingPJ. A review of laser treatment for symptomatic BPH (Benign Prostatic Hyperplasia). Curr Urol Rep. 2016;17(6):45.27053186
   PubMed Web of Science ®Google Scholar
• OlceseSP, DerosaR, KernSQ, LustikMB, SterbisJR, McMannLP. Comparison of outcomes after TURP versus photoselective vaporization of the prostate with respect to trainee involvement utilizing ACS NSQIP. Prostate Cancer Prostatic Dis. 2014;17(3):227–232.24732080
   PubMed Web of Science ®Google Scholar
• BozziniG, SevesoM, MelegariS, et al. Thulium laser enucleation (ThuLEP) versus transurethral resection of the prostate in saline (TURis): a randomized prospective trial to compare intra and early postoperative outcomes. Actas Urológicas Españolas. 2017;41(5):309–315.28062085
   PubMed Web of Science ®Google Scholar
• HerrmannTR, LiatsikosEN, NageleU, TraxerO, MerseburgerAS. Eau Guidelines Panel on Lasers T. EAU guidelines on laser technologies. Eur Urol. 2012;61(4):783–795.22285403
   PubMed Web of Science ®Google Scholar
• ZornKC, LibermanD. GreenLight 180W XPS photovaporization of the prostate: how I do it. Can J Urol. 2011;18(5):5918–5926.22018158
   PubMed Web of Science ®Google Scholar
• HerrmannTR, BachT, ImkampF, et al. Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol. 2010;28(1):45–51.20063164
   PubMed Web of Science ®Google Scholar
• XiaSJ, ZhuoJ, SunXW, HanBM, ShaoY, ZhangYN. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol. 2008;53(2):382–389.17566639
   PubMed Web of Science ®Google Scholar
• HashimH, WorthingtonJ, AbramsP, et al. Thulium laser transurethral vaporesection of the prostate versus transurethral resection of the prostate for men with lower urinary tract symptoms or urinary retention (UNBLOCS): a randomised controlled trial. Lancet. 2020;396(10243):50–61.32622397
   PubMed Web of Science ®Google Scholar
• CornuJN, HerrmannT, TraxerO, MatlagaB. Prevention and management following complications from endourology procedures. Eur Urol Focus. 2016;2(1):49–59.28723449
   PubMedGoogle Scholar
• Olapade-OlaopaEO, SolomonLZ, CarterCJ, AhiakuEK, ChivertonSG. Haematuria and clot retention after transurethral resection of the prostate: a pilot study. Br J Urol. 1998;82(5):624–627.9839574
   PubMedGoogle Scholar
• OrihuelaE, Pow-SangM, MotamediM, CowanDF, WarrenMM. Mechanism of healing of the human prostatic urethra following thermal injury. Urology. 1996;48(4):600–608.8886067
   PubMed Web of Science ®Google Scholar
• ShamoutS, CarlsonK, BrotherhoodHL, CrumpT, BaverstockR. Incidence and predictors of early and late hospital readmission after transurethral resection of the prostate: a population-based cohort study. BJU Int. 2020;127:238–246.32790101
   PubMed Web of Science ®Google Scholar
• JacksonRE, CasanovaNF, WallnerLP, et al. Risk factors for delayed hematuria following photoselective vaporization of the prostate. J Urol. 2013;190(3):903–908.23538242
   PubMed Web of Science ®Google Scholar
• OzdalOL, OzdenC, BenliK, GokkayaS, BulutS, MemisA. Effect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled study. Prostate Cancer Prostatic Dis. 2005;8(3):215–218.15999118
   PubMed Web of Science ®Google Scholar
• BansalA, AroraA. Transurethral resection of prostate and bleeding: a prospective, randomized, double-blind placebo-controlled trial to see the efficacy of short-term use of finasteride and dutasteride on operative blood loss and prostatic microvessel density. J Endourol. 2017;31(9):910–917.28650680
   PubMed Web of Science ®Google Scholar
• YangTY, ChenM, LinWR, et al. Preoperative treatment with 5alpha-reductase inhibitors and the risk of hemorrhagic events in patients undergoing transurethral resection of the prostate - A population-based cohort study. Clinics. 2018;73:e264.29538495
   PubMed Web of Science ®Google Scholar
• YeeCH, WongJH, ChiuPK, et al. Secondary hemorrhage after bipolar transurethral resection and vaporization of prostate. Urol Ann. 2016;8(4):458–463.28057992
   PubMedGoogle Scholar
• RuhleA, BlarerJ, OehmeF, et al. Safety and effectiveness of bipolar transurethral resection of the prostate in patients under ongoing oral anticoagulation with coumarins or antiplatelet drug therapy compared to patients without anticoagulation/antiplatelet therapy. J Endourol. 2019;33(6):455–462.30834782
   PubMed Web of Science ®Google Scholar
• PalmisanoF, BoeriL, FontanaM, et al. Incidence and predictors of readmission within 30 days of transurethral resection of the prostate: a single center European experience. Sci Rep. 2018;8(1):6575.29700356
   PubMed Web of Science ®Google Scholar